STAAR Surgical (NASDAQ:STAA – Get Free Report) and Remedent (OTCMKTS:REMI – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings.
Earnings & Valuation
This table compares STAAR Surgical and Remedent”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
STAAR Surgical | $313.90 million | 3.91 | -$20.21 million | ($1.93) | -12.90 |
Remedent | $990,000.00 | N/A | -$270,000.00 | ($0.01) | -0.02 |
Risk and Volatility
STAAR Surgical has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Remedent has a beta of -0.3, meaning that its share price is 130% less volatile than the S&P 500.
Institutional and Insider Ownership
96.7% of STAAR Surgical shares are held by institutional investors. 0.6% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current recommendations and price targets for STAAR Surgical and Remedent, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
STAAR Surgical | 1 | 10 | 0 | 0 | 1.91 |
Remedent | 0 | 0 | 0 | 0 | 0.00 |
STAAR Surgical currently has a consensus target price of $20.67, indicating a potential downside of 17.00%. Given STAAR Surgical’s stronger consensus rating and higher probable upside, research analysts plainly believe STAAR Surgical is more favorable than Remedent.
Profitability
This table compares STAAR Surgical and Remedent’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
STAAR Surgical | -42.45% | -16.11% | -12.54% |
Remedent | N/A | N/A | N/A |
About STAAR Surgical
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
About Remedent
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient’s teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.
Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.